These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. The pharmacology of sulfonylureas. Skillman TG; Feldman JM Am J Med; 1981 Feb; 70(2):361-72. PubMed ID: 6781341 [TBL] [Abstract][Full Text] [Related]
5. Interactions of sulfonylureas with plasma proteins. Hsu PL; Ma JK; Luzzi LA J Pharm Sci; 1974 Apr; 63(4):570-3. PubMed ID: 4208196 [No Abstract] [Full Text] [Related]
6. [Protein binding of glisoxepide and its influence on the protein binding of phenprocoumon]. Schlossmann K Arzneimittelforschung; 1974 Mar; 24(0):392-7. PubMed ID: 4408096 [No Abstract] [Full Text] [Related]
7. Metabolic effects of hypoglycemic sulfonylureas. V. In vitro effects of sulfonylureas on mitochondrial adenosine triphosphatase activity. Debeer L; Mannaerts G; De Schepper PJ Biochem Pharmacol; 1974 Jan; 23(2):251-8. PubMed ID: 4273213 [No Abstract] [Full Text] [Related]
8. Characterization of the binding of sulfonylurea drugs to HSA by high-performance affinity chromatography. Joseph KS; Hage DS J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Jun; 878(19):1590-8. PubMed ID: 20435530 [TBL] [Abstract][Full Text] [Related]
10. Nuclear magnetic resonance study of the binding of tolbutamide and chlorpropamide to bovine serum albumin. Ueda H; Higashiyama K; Nagai T Chem Pharm Bull (Tokyo); 1980; 28(4):1016-21. PubMed ID: 7418103 [No Abstract] [Full Text] [Related]
11. METABOLISM OF ANTIDIABETIC SULFONYLUREAS IN MAN. I. BIOLOGICAL HALF-LIVES OF THE P-ACETYLBENZENESULFONYLUREAS, U-18536 AND ACETOHEXAMIDE AND THEIR METABOLITES. SMITH DL; VECCHIO TJ; FORIST AA Metabolism; 1965 Mar; 14():229-40. PubMed ID: 14261407 [No Abstract] [Full Text] [Related]
12. Drug interactions of gliclazide and other sulfonylureas in protein binding in vitro and in hypoglycemic effect in rats. Fujii T; Nakamura K; Furukawa H; Watanabe M; Kuwashima J; Miyazaki H; Kawashima K; Kuzuya T Arzneimittelforschung; 1983; 33(11):1535-7. PubMed ID: 6686448 [TBL] [Abstract][Full Text] [Related]
13. The effect of different oral anticoagulants on diphenylhydantoin (DPH) and tolbutamide metabolism. Skovsted L; Kristensen M; Hansen M; Siersbaek-Nielsen K Acta Med Scand; 1976; 199(6):513-5. PubMed ID: 59517 [TBL] [Abstract][Full Text] [Related]
14. The binding of sulphonylureas to serum albumin. Crooks MJ; Brown KF J Pharm Pharmacol; 1974 May; 26(5):304-11. PubMed ID: 4153105 [No Abstract] [Full Text] [Related]
15. Binding of sulfonylurea derivatives to bovine serum albumin: part I. Binding of SPC--703, tolbutamide, glibornuride and glipizide. Wójcikowski C; Szlabowicz D Pol J Pharmacol Pharm; 1977; 29(5):469-75. PubMed ID: 22846 [No Abstract] [Full Text] [Related]
16. Binding of sulfonylureas to serum albumin: a response. Judis J J Pharm Sci; 1973 Nov; 62(11):1906-7. PubMed ID: 4758103 [No Abstract] [Full Text] [Related]
17. Nonenzymatic glucosylation of human serum albumin and its influence on binding capacity of sulfonylureas. Tsuchiya S; Sakurai T; Sekiguchi S Biochem Pharmacol; 1984 Oct; 33(19):2967-71. PubMed ID: 6487349 [TBL] [Abstract][Full Text] [Related]
18. Measurement of antidiabetic sulfonylureas in serum by gas chromatography with electron-capture detection. Braselton WE; Bransome ED; Huff TA Diabetes; 1977 Jan; 26(1):50-7. PubMed ID: 830565 [TBL] [Abstract][Full Text] [Related]
19. An electrophoretic investigation of the binding of 3-14C coumarin to rat serum proteins. Piller NB; Schmitt LH Experientia; 1977 Aug; 33(8):1072-4. PubMed ID: 70376 [TBL] [Abstract][Full Text] [Related]
20. SERUM CONCENTRATION AND URINARY EXCRETION OF ORAL SULFONYLUREA COMPOUNDS: RELATION TO DIABETIC CONTROL. SHELDON J; ANDERSON J; STONER L Diabetes; 1965 Jun; 14():362-7. PubMed ID: 14298920 [No Abstract] [Full Text] [Related] [Next] [New Search]